Xcout Intel
Arbor Biotechnologies, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Arbor Biotechnologies, Inc. among biotechnology companies — ranked by similarity to what Arbor Biotechnologies, Inc. actually does, not by market-cap band.
Subscribe to see Arbor Biotechnologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. is a next-generation gene editing company focused on discovering and developing precise genetic medicines for rare and complex diseases.
Arbor Biotechnologies, Inc. at a glance
Arbor Biotechnologies, Inc. is a biotechnology company headquartered in United States. It has raised at least $304.5M across the 3 funding rounds on record. Its most recent funding round, Series C-2, raised $73.9M in March 2025. Xcout tracks 2 named people at Arbor Biotechnologies, Inc., including David Scott (co-founder).
Arbor Biotechnologies, Inc. leadership
- David Scottco-founder
- Feng Zhangco-founder
Arbor Biotechnologies, Inc. funding rounds
At least $304.5M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C-2 | $73.9M | 3 named | |
| Series C | $215M | 14 named | |
| Series A | $15.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Arbor Biotechnologies, Inc. competitors
Ranked by semantic similarity — how close each company is to Arbor Biotechnologies, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
Similar biotechnology company
AskBio is a clinical-stage gene therapy company that develops adeno-associated virus (AAV) gene therapies to treat genetic and complex disorders. The company focuses on advancing genetic medicine through its proprietary technology platforms, manufacturing processes, and clinical trials.
Similar biotechnology company
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Biotech
SpliceBio is a clinical-stage genetic medicines company that develops gene therapies using a proprietary Protein Splicing platform. The company focuses on treating diseases caused by mutations in large genes, with a lead clinical program targeting Stargardt disease.
Similar biotechnology company
Verve Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, dedicated to pioneering single-course gene editing medicines for cardiovascular disease.
Biotech
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Similar biotechnology company
Nerai Bioscience AG is a biotechnology company headquartered in Zurich, Switzerland, that is focused on redefining genetic medicine.
Similar biotechnology company
Averna Therapeutics is a biotechnology company developing genomic medicines utilizing RNA and lipid nanoparticle technologies. The company focuses on safe and efficient gene insertion and the treatment of rare genetic diseases through research and development teams located in Boston and Israel.
Similar biotechnology company
Epicrispr Biotechnologies is a pioneering therapeutics company dedicated to developing advanced genetic medicines. The organization focuses on scientific research, platforms, and clinical pipelines to treat serious diseases.
Similar biotechnology company
Artizan Biosciences, Inc. is a biotechnology company headquartered in New Haven, Connecticut, focused on precision medicine and microbiome-driven therapeutics.
Similar biotechnology company
Aro Biotherapeutics is a U.S. biotechnology company developing targeted therapeutics using its Centyrin protein platform, including delivery of genetic medicines to specific tissues and cells. It serves patients with serious diseases and partners or works with biopharmaceutical organizations to advance targeted drug-development programs.
Similar biotechnology company
Neuron23 is a biotechnology company founded in 2018 that focuses on developing precision therapeutics for genetic diseases. Headquartered in South San Francisco, California, the company relies on a team of scientific experts and entrepreneurs.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Arbor Biotechnologies, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Arbor Biotechnologies, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →